As the global market for biopharmaceutical research outsourcing continues to flourish, the annual BOS Basel Conference has once again drawn worldwide attention. Since its inception in 2006, the Biotech Outsourcing Strategies (BOS) Events has become a barometer for the research outsourcing industry in Europe and globally. The organizers invite industry experts, business leaders, and scholars to explore key issues in biotech outsourcing, share successful experiences, and establish and strengthen collaborative relationships through a series of keynote speeches, specialized discussions, and roundtable forums.

BOS Basel 2024 is set to kick off in this June. This year’s event will continue to focus on the outsourcing of CMC (Chemistry, Manufacturing, and Controls) for small molecules and biologics, with special attention to outsourcing developments in novel therapeutic areas (New Drug Modalities).

At this year’s conference, Porton will showcase its end-to-end global CDMO service capabilities and the differentiated advantages it offers to customers. Whether its new drug development, process transfer optimization, or commercial manufacturing, Porton is committed to actively listening to customer needs and providing efficient, precise CDMO solutions.

On May 22, 2024, Porton PharmaTech celebrated the grand opening of its state-of-the-art research and development laboratories for active pharmaceutical ingredients (APIs) and small molecules in Mengeš. This event marks another significant milestone in Porton’s globalization journey, following the acquisition of the US-based CRO, J-STAR Research Inc., in 2017. Globalization remains our top strategic priority at Porton, as we strive to establish R&D and manufacturing footprints in the United States and Europe. This expansion is designed to meet the growing demands of our global clients for enhanced supply chain security, high-quality, innovative, and reliable services.

Furthermore, this BOS Basel will continue the tradition of previous events by featuring four core activities: Partnering; Exhibition, Informal Networking and more. Porton will actively participate in these segments, sharing experiences, building connections, and fostering collaborations with global peers. We look forward to gathering with industry colleagues in the beautiful city of Basel to witness the brilliant future of the biotech outsourcing field together!

For business meeting appointments,

please contact: business@portonpharma.com.